WINDTREE THERAPEUTICS INC /DE/ Recognition of Deferred Revenue
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Recognition of Deferred Revenue of -$121.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2018-11-14
- WINDTREE THERAPEUTICS INC /DE/ recognition of deferred revenue for the quarter ending 2018-09-30 was -$681.00K.
- WINDTREE THERAPEUTICS INC /DE/ recognition of deferred revenue for the quarter ending 2018-06-30 was $356.00K.
- WINDTREE THERAPEUTICS INC /DE/ recognition of deferred revenue for the quarter ending 2018-03-31 was $204.00K.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 9 month |
|---|---|---|---|
| 2018-09-30 | -$681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$325.00K derived: sum of 2 quarters · filed 2018-11-14 | -$121.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $560.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $204.00K 10-Q · filed 2018-05-21 | ||
| 2017-09-30 | -$147.00K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |